Partner Content Partner Content MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immun... MHRA, Pfizer & Autolus Sign Up for Immuno-Oncology 2018
Partner Content Partner Content Less than 4 Weeks until Immuno-Therapy Experts Gather at the... Less than 4 Weeks until Immuno-Oncology Conference
Partner Content Partner Content Invitation from Chair of this year’s Immuno-Oncology Confere... Invitation from Chair of Immuno-Oncology Conference
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
